Report cover image

CC Chemokine Receptor Type 5 Global Market Report 2025

Published Sep 10, 2025
Length 250 Pages
SKU # BRC20385190

Description

CC Chemokine Receptor Type 5 Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cc chemokine receptor type 5 market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for cc chemokine receptor type 5 ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cc chemokine receptor type 5 market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Type: BMS-813160; AG-1105; CCL-14; DS-001; Other Types

2) By Distribution Channel: Hospitals; Clinics; Online Pharmacies; Retail Pharmacies

3) By Application: Infectious Disease; Gastrointestinal; Immunology; Oncology; Other Applications

4) By End User: Research Institutes; Pharmaceutical Companies; Healthcare Facilities

Subsegments:

1) By BMS-813160: CCR5 Antagonist For HIV Treatment; CCR5 Antagonist For Inflammatory Diseases

2) By AG-1105: CCR5 Antagonist For Autoimmune Disorders; CCR5 Antagonist For Cancer Therapy

3) By CCL-14: Chemokine Ligand For Targeted Therapy; CCL-14 For Immune Modulation

4) By DS-001: CCR5 Inhibitor For Cancer Treatment; DS-001 For Inflammatory Disease Management

5) By Other Types: Novel CCR5 Antagonists; Dual-Target CCR5 Antagonists

Companies Mentioned: Pfizer Inc.; Sorrento Therapeutics; Merck & Co. Inc.; AbbVie Inc.; Sanofi SA; Avexa Limited; Thermo Fisher Scientific Inc.; AstraZeneca plc; Novartis AG; GlaxoSmithKline plc; Takeda Pharmaceutical; Gilead Sciences Inc.; Vertex Pharmaceuticals; Ono Pharmaceutical Co Ltd; Abcam Limited; BioLegend Inc.; R&D Systems Inc; American Gene Technologies International Inc; NSJ Bioreagents; Cytodyn Inc.; Affinity Biosciences

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

250 Pages
1. Executive Summary
2. Cardiovascular Clinical Trials Market Characteristics
3. Cardiovascular Clinical Trials Market Trends And Strategies
4. Cardiovascular Clinical Trials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Cardiovascular Clinical Trials Growth Analysis And Strategic Analysis Framework
5.1. Global Cardiovascular Clinical Trials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Cardiovascular Clinical Trials Market Growth Rate Analysis
5.4. Global Cardiovascular Clinical Trials Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Cardiovascular Clinical Trials Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Cardiovascular Clinical Trials Total Addressable Market (TAM)
6. Cardiovascular Clinical Trials Market Segmentation
6.1. Global Cardiovascular Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Phase I
Phase II
Phase III
Phase IV
6.2. Global Cardiovascular Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Interventional
Observational
Expanded Access
6.3. Global Cardiovascular Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acute Coronary Syndrome
Coronary Artery Disease
Ischemic Heart Disease
Pulmonary Arterial Hypertension
Stroke
Cardiac Arrhythmias
Heart Failure
Other Indications
6.4. Global Cardiovascular Clinical Trials Market, Sub-Segmentation Of Phase I, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
First-in-Human Trials
Dose Escalation Studies
Safety and Tolerability Studies
Pharmacokinetics And Pharmacodynamics Studies
6.5. Global Cardiovascular Clinical Trials Market, Sub-Segmentation Of Phase II, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Efficacy Studies
Optimal Dosage And Administration Route Studies
Early Safety And Efficacy Trials
Biomarker Development Trials
6.6. Global Cardiovascular Clinical Trials Market, Sub-Segmentation Of Phase III, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Large-Scale Efficacy Trials
Randomized Controlled Trials (RCTs)
Long-Term Safety And Efficacy Studies
Multicenter Trials
6.7. Global Cardiovascular Clinical Trials Market, Sub-Segmentation Of Phase IV, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Post-Marketing Surveillance
Long-Term Safety Studies
Real-World Evidence (RWE) Studies
Comparative Effectiveness Research
7. Cardiovascular Clinical Trials Market Regional And Country Analysis
7.1. Global Cardiovascular Clinical Trials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Cardiovascular Clinical Trials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Cardiovascular Clinical Trials Market
8.1. Asia-Pacific Cardiovascular Clinical Trials Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cardiovascular Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Cardiovascular Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Cardiovascular Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Cardiovascular Clinical Trials Market
9.1. China Cardiovascular Clinical Trials Market Overview
9.2. China Cardiovascular Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Cardiovascular Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Cardiovascular Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Cardiovascular Clinical Trials Market
10.1. India Cardiovascular Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Cardiovascular Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Cardiovascular Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Cardiovascular Clinical Trials Market
11.1. Japan Cardiovascular Clinical Trials Market Overview
11.2. Japan Cardiovascular Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Cardiovascular Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Cardiovascular Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Cardiovascular Clinical Trials Market
12.1. Australia Cardiovascular Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Cardiovascular Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Cardiovascular Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Cardiovascular Clinical Trials Market
13.1. Indonesia Cardiovascular Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Cardiovascular Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Cardiovascular Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Cardiovascular Clinical Trials Market
14.1. South Korea Cardiovascular Clinical Trials Market Overview
14.2. South Korea Cardiovascular Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Cardiovascular Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Cardiovascular Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Cardiovascular Clinical Trials Market
15.1. Western Europe Cardiovascular Clinical Trials Market Overview
15.2. Western Europe Cardiovascular Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Cardiovascular Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Cardiovascular Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Cardiovascular Clinical Trials Market
16.1. UK Cardiovascular Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Cardiovascular Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Cardiovascular Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Cardiovascular Clinical Trials Market
17.1. Germany Cardiovascular Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Cardiovascular Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Cardiovascular Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Cardiovascular Clinical Trials Market
18.1. France Cardiovascular Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Cardiovascular Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Cardiovascular Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Cardiovascular Clinical Trials Market
19.1. Italy Cardiovascular Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Cardiovascular Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Cardiovascular Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Cardiovascular Clinical Trials Market
20.1. Spain Cardiovascular Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Cardiovascular Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Cardiovascular Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Cardiovascular Clinical Trials Market
21.1. Eastern Europe Cardiovascular Clinical Trials Market Overview
21.2. Eastern Europe Cardiovascular Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Cardiovascular Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Cardiovascular Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Cardiovascular Clinical Trials Market
22.1. Russia Cardiovascular Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Cardiovascular Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Cardiovascular Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Cardiovascular Clinical Trials Market
23.1. North America Cardiovascular Clinical Trials Market Overview
23.2. North America Cardiovascular Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Cardiovascular Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Cardiovascular Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Cardiovascular Clinical Trials Market
24.1. USA Cardiovascular Clinical Trials Market Overview
24.2. USA Cardiovascular Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Cardiovascular Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Cardiovascular Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Cardiovascular Clinical Trials Market
25.1. Canada Cardiovascular Clinical Trials Market Overview
25.2. Canada Cardiovascular Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Cardiovascular Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Cardiovascular Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Cardiovascular Clinical Trials Market
26.1. South America Cardiovascular Clinical Trials Market Overview
26.2. South America Cardiovascular Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Cardiovascular Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Cardiovascular Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Cardiovascular Clinical Trials Market
27.1. Brazil Cardiovascular Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Cardiovascular Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Cardiovascular Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Cardiovascular Clinical Trials Market
28.1. Middle East Cardiovascular Clinical Trials Market Overview
28.2. Middle East Cardiovascular Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Cardiovascular Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Cardiovascular Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Cardiovascular Clinical Trials Market
29.1. Africa Cardiovascular Clinical Trials Market Overview
29.2. Africa Cardiovascular Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Cardiovascular Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Cardiovascular Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Cardiovascular Clinical Trials Market Competitive Landscape And Company Profiles
30.1. Cardiovascular Clinical Trials Market Competitive Landscape
30.2. Cardiovascular Clinical Trials Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
30.2.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
31. Cardiovascular Clinical Trials Market Other Major And Innovative Companies
31.1. Novartis AG
31.2. Eli Lilly and Company
31.3. Gilead Sciences Inc.
31.4. Amgen Inc.
31.5. Boehringer Ingelheim International GmbH
31.6. Merck & Co. Inc.
31.7. Baxter International Inc.
31.8. IQVIA Holdings Inc.
31.9. SGS S.A.
31.10. PPD Inc.
31.11. WuXi AppTec Co. Ltd.
31.12. Caidya
31.13. Syneos Health Inc.
31.14. Charles River Laboratories International Inc.
31.15. Sanofi
32. Global Cardiovascular Clinical Trials Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Cardiovascular Clinical Trials Market
34. Recent Developments In The Cardiovascular Clinical Trials Market
35. Cardiovascular Clinical Trials Market High Potential Countries, Segments and Strategies
35.1 Cardiovascular Clinical Trials Market In 2029 - Countries Offering Most New Opportunities
35.2 Cardiovascular Clinical Trials Market In 2029 - Segments Offering Most New Opportunities
35.3 Cardiovascular Clinical Trials Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.